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Bacteria have evolved the ability to produce a wide range of
structurally complex natural products historically called “secondary”
metabolites. Although some of these compounds have been
identified as bacterial communication cues, more frequently nat-
ural products are scrutinized for antibiotic activities that are rel-
evant to human health. However, there has been little regard for
how these compounds might otherwise impact the physiology of
neighboring microbes present in complex communities. Bacillus
cereus secretes molecules that activate expression of biofilm genes
in Bacillus subtilis. Here, we use imaging mass spectrometry to
identify the thiocillins, a group of thiazolyl peptide antibiotics, as
biofilm matrix-inducing compounds produced by B. cereus. We
found that thiocillin increased the population of matrix-producing
B. subtilis cells and that this activity could be abolished by multiple
structural alterations. Importantly, a mutation that eliminated thi-
ocillin’s antibiotic activity did not affect its ability to induce biofilm
gene expression in B. subtilis. We go on to show that biofilm in-
duction appears to be a general phenomenon of multiple structur-
ally diverse thiazolyl peptides and use this activity to confirm the
presence of thiazolyl peptide gene clusters in other bacterial spe-
cies. Our results indicate that the roles of secondary metabolites
initially identified as antibiotics may have more complex effects—
acting not only as killing agents, but also as specific modulators of
microbial cellular phenotypes.
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Natural-product antibiotics have proven to be exquisite toolsfor combating infectious disease. Increasingly, a more elab-
orate role is being realized for these molecules formerly called
“secondary” metabolites: as key signaling molecules for in-
terspecies and intraspecies bacterial communication (1–7). Anti-
biotics at subinhibitory concentrations can trigger nonlethal
physiological responses in human pathogens, including quorum
sensing, virulence factor production, or biofilm formation (8–12).
In some cases this activity has been tentatively linked to the
mechanism of antibiosis of the small molecule. For example,
quorum-sensing induction by the aminoglycoside tobramycin
arises from sublethal inhibition of translation by RhlI/R system
components (13).
More broadly, many natural-product antibiotics trigger biofilm
formation, which has been interpreted as evidence that forming
biofilms might be a general mechanism of defense against
competitors (14). Biofilms are communities of bacterial cells
living in a sticky, self-produced extracellular matrix on either
a liquid or solid surface (15). The formation of bacterial biofilms
can be both beneficial—such as on plant roots (16–18) or in
wastewater treatment plants (19)—or detrimental—such as on
in-dwelling medical devices or during infection (20, 21). Thus,
understanding the chemical signals that induce and inhibit bio-
film formation in bacteria has broad relevance.
The ability to form biofilms, like many bacterial phenotypes, is
a result of bacteria differentiating into transcriptionally distinct
cell types (22–24). Bacillus subtilis is a model organism whose
cellular differentiation capabilities have been well characterized
(23). Other members of the genus Bacillus can stimulate B.
subtilis to differentiate into biofilm-matrix–producing cells (25).
We monitored these interactions using a fluorescent transcrip-
tional reporter for matrix gene expression. This reporter (PtapA–
yfp) consists of PtapA [the promoter for the tapA operon (TasA
anchoring/assembly protein A) that encodes TasA, the major
protein component of B. subtilis biofilm matrix (26)], driving
production of a yfp gene (encoding yellow fluorescent protein,
YFP). Thus, when these B. subtilis cells are producing biofilm
matrix, they also produce YFP. In particular, members of the
Bacillus genus elicited B. subtilis biofilm formation via two dis-
tinct mechanisms (25). Some induced the matrix reporter via the
sensor histidine kinase kinD (which activates the master tran-
scriptional regulator for biofilm formation, Spo0A); others in-
duced the matrix reporter through a separate Spo0A-dependent
mechanism (25). This latter activity was linked to putative se-
creted metabolites present in conditioned medium that also had
antibiotic activity (25).
Here, we pursue the identification of one of the biofilm-
inducing metabolites secreted by Bacillus cereus ATCC 14579 that
induced matrix formation in B. subtilis via both mechanisms (25).
Using matrix-assisted laser desorption/ionization time-of-flight
imaging mass spectrometry (MALDI-TOF IMS), we identified
the thiocillins, members of the thiazolyl peptide class of natural
products, as B. cereus-produced compounds that trigger biofilm
formation in B. subtilis in a kinD-independent manner. The
thiocillins are ribosomally encoded, posttranslationally modified
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peptide antibiotics that exert their activity by interfering with the
interaction between the 23S rRNA and the protein L11 of the
50S ribosome (27, 28). The biosynthesis genes for the thiocillins
have recently been elucidated (29), leading to the identification
of related thiazolyl biosynthesis clusters in the genomes of diverse
bacterial taxa. We show, using purified compounds and genetically
modified variants of B. cereus, that the kinD-independent matrix-
inducing activity of the thiocillins is independent of the antibiotic
activity for which they are known. We further examine the struc-
ture–activity relationship of the thiocillins’ matrix-induction ability,
and use this activity to identify putative thiazolyl peptide gene
clusters in other Bacillus species.
Results
Using IMS to Connect Phenotype to Chemotype. We indirectly
monitored the response of B. subtilis to environmental signals
that activated biofilm matrix production using the PtapA–yfp
transcriptional fluorescent reporter strain. We used this strain to
examine the consequences of coculturing B. subtilis with B. cereus
under conditions in which B. subtilis does not normally produce
biofilms (Fig. 1A). The B. subtilis colonies closest to B. cereus
fluoresced, indicating that tapA gene expression is activated in
these cells (Fig. 1B; ref. 25). We hypothesized that this biofilm
activation was due to compounds secreted by B. cereus that dif-
fused through the agar of the assay plate and altered the cellular
physiology of B. subtilis.
The striking visual distribution of this coculture interaction
inspired us to use MALDI-TOF IMS to connect this fluorescent
signal with the molecular cue(s) responsible for inducing it.
MALDI-TOF IMS involves collecting numerous mass spectra in
a grid-like pattern across 2D samples, which can then be used to
correlate chemical ion distributions with spatial biological phe-
notypes (30, 31). From the IMS data collected, we looked for
ions whose spatial distributions corresponded to the region
where the fluorescent signal for matrix was activated. One of
these was an ion with m/z = 1,142, identified in linear negative
mode (Fig. 1C and Fig. S1A). When we searched for known
compounds produced by B. cereus with this molecular weight, we
identified a variant of thiocillin, micrococcin P1 [M-H]− (Fig.
1D; ref. 29) as a potential match, suggesting that the thiocillins
may be the cue produced by B. cereus that induces matrix pro-
duction and PtapA–yfp fluorescence in B. subtilis. During the
normal expression of the tcl biosynthesis cluster in B. cereus, a
number of structural variants of thiocillin of different molecular
weight are produced (29); we observed peaks corresponding to the
masses of many of these structural variants, supporting our hy-
pothesis that these ions observed in our IMS data may represent
the thiocillins; we observed m/z = 1,141 micrococcin P2, [M-H]−),
1,155 (thiocillin 3, [M-H]−), 1,181 (thiocillin 1, [M-H+Na]−), 1,193
(YM-266184, [M-H+Na]−), and 1,195 (thiocillin 2, [M-H+Na]−)
(Fig. S1B). We will refer to the thiocillins by their generic name
here, unless using a specific purified variant.
Thiocillins Are Partially Responsible for B. cereus’ Ability to Induce
B. subtilis Biofilm Matrix. Using a mutant of B. cereus that does not
contain the structural genes required to produce the thiocillins
(ΔtclE-H) (32), we examined the ability of wild-type (WT) andΔtclE-
H B. cereus to induce PtapA-yfp expression in B. subtilis (Fig. 2A). Both
the visual fluorescence of these interactions and their quantification
indicate that the thiocillins are responsible for approximately half of
the matrix-inducing ability of B. cereus (Fig. 2A, Left).
B. cereus uses two distinct mechanisms to induce PtapA-yfp
fluorescence in B. subtilis: One requires the sensor histidine ki-
nase KinD, and the other correlates with an antibiotic activity.
We previously proposed that this latter mechanism increases
biofilm matrix production via a cell-type-specific killing of non-
matrix-producing cells, thus increasing the subpopulation of
matrix producers (25). To investigate which of these two B. cereus
activities thiocillin might be responsible for, we examined the
ability of these B. cereus strains to induce PtapA-yfp expression
in a B. subtilis kinD strain. These data (Fig. 2A, Right) show that
the B. cereus WT–B. subtilis kinD interaction has approximately
half of the overall fluorescence observed in the B. cereus WT–
B. subtilis WT interaction. This remaining signal is thus attributable
to the activity produced by B. cereus that is acting via the kinD-
independent pathway; it is virtually eliminated in the B. cereus
ΔtclE-H–B. subtilis kinD interaction (Fig. 2A), indicating that the
thiocillins are responsible for the kinD-independent activation of
matrix induction in B. subtilis.
The Matrix-Inducing Activity of the Thiocillins Is Separable from Their
Antibiotic Activity. To test whether the thiocillins were increasing
PtapA–yfp fluorescence in B. subtilis by specifically killing non-
matrix-producing cells, we examined the activity of a B. cereus
strain engineered to produce thiocillins containing a T4V mu-
tation (Fig. 2B); T4V thiocillin has no antibiotic activity against B.
subtilis (32) (Fig. S2). Remarkably, when we grew this B. cereus
strain in our matrix-induction assay, it induced PtapA–yfp fluores-
cence in B. subtilis to the same extent as WT B. cereus (Fig. 2 A
and B). B cereus producing the T4V thiocillin variant also induced
changes in B. subtilis colony morphology, where wrinkling corre-
lates with biofilm production (Fig. S2). This finding was true for
both the WT and kinD B. subtilis interaction (Fig. 2B). These
results indicate that T4V thiocillin induces both PtapA gene ex-
pression and changes in colony morphology associated with
biofilm formation, and thus that the antibiotic activity of the



































Fig. 1. IMS used to identify a matrix-inducing compound produced by B. cereus. (A) B. cereus grown as a colony on a microcolony lawn of B. subtilis. (Scale
bar: 0.5 cm.) (B) This B. subtilis strain contains a fluorescent transcriptional reporter for biofilm matrix gene expression (PtapA–yfp); the B. subtilis colonies
closest to B. cereus are fluorescing, indicating that matrix gene expression is activated. (C) IMS data showing the distribution of an ion withm/z = 1,142 (linear
negative mode) that corresponds to the area of fluorescence observed in B; relative scale is from 0.7 to 1.8. (D) Structure of micrococcin P1, a thiazolyl peptide
antibiotic produced by B. cereus with a molecular weight consistent with it being the ion observed in C.









Purified Thiocillin Increases the Proportion of Matrix-Producing B.
subtilis Cells. To determine whether purified thiocillin has the abil-
ity to activate matrix gene expression in B. subtilis, we examined its
effect on tapA gene expression. We first spotted 450 ng of purified
YM-266183 or T4V thiocillin (Fig. S3) on microcolony lawns of B.
subtilis PtapA–yfp and quantified the resulting fluorescence (Fig. 2C).
Both the antibiotically active and antibiotically dead versions of the
thiocillins induced PtapA–yfp expression to the same extent (Fig. 2C).
Our T4V data indicated that the antibiotic activity of thiocillin
was not necessary for PtapA–yfp matrix induction in this structural
mutant. To explore whether the antibiotic activity was also un-
necessary for matrix induction by the native thiocillins, we de-
termined thiocillin’s minimal inhibitory concentration (MIC). To
do this assessment, we grew B. subtilis in liquid shaking culture in
non-matrix-inducing growth medium [Lennox Luria broth (LB)]
in the presence of purified YM-266183 or DMSO (as a control)
and measured the OD600 absorbance over time. MICs are typi-
cally determined as an endpoint after overnight growth in varying
concentrations of the antibiotic. We noted that this MIC con-
centration (50 nM) was significantly higher than the concentra-
tion at which B. subtilis showed no growth inhibition at any point
during growth (3.125 nM) (Fig. S4).
We selected a concentration intermediate between these two
concentrations (12.5 nM), and selected a time point (9 h) at which
there was no difference in the OD600 of the DMSO- or thiocillin-
treated cultures (Fig. 3A). At this time point, we fixed the cells with
paraformaldehyde and measured the fluorescence of individual
cells using flow cytometry. When B. subtilis PtapA–yfp cells were
grown in the presence of DMSO, only a small percentage of the
population was fluorescent (11%), whereas a much larger per-
centage of the population (36–41%) expressed PtapA–yfp when the
cells were grown with YM-266183 (Fig. 3B). Interestingly, even at
earlier time points (4 h), when B. subtilis growth is being inhibited,
the percentage of the population that was expressing matrix was still
higher in the thiocillin-treated cells than in those treated with
DMSO (56% vs. 34%) (Fig. S4C). Thus, purified thiocillin has
the ability to increase the proportion of matrix-producing cells
when added to B. subtilis liquid cultures, irrespective of its anti-
biotic activity.
Matrix Induction Is a General Property of Thiazolyl Peptides. The
thiocillins are ribosomally synthesized and posttranslationally modi-
fied peptides (RiPPs) in the class of bacteriocins known as thiazolyl
peptides (33). We were therefore curious whether the biofilm-
inducing activity of thiocillin was a generic property of this class of
metabolites. We purified a range of structurally and functionally di-
verse thiazolyl peptides (thiostrepton, nosiheptide, berninamycin, and
GE37468; Fig. S5), and tested whether they influenced PtapA–yfp
expression in B. subtilis. We spotted 450 ng of these purified com-
pounds (comparable to the amount of thiocillin used in Fig. 2C) onto
B. subtilis WT and kinD lawns and quantified the resulting fluores-
cence (Fig. 4). All of these thiazolyl peptides induced PtapA–yfp
expression. There was no significant difference between the
fluorescence induction of any individual thiopeptide on the WT or
kinD B. subtilis lawns (P > 0.1), indicating that, similar to thiocillin, all
of these thiopeptides activate biofilm gene expression in a kinD-
independent manner. Both thiostrepton and berninamycin demon-
strated antibiotic activity at these concentrations. These data and
those from Fig. 2 and 3 demonstrate that thiazolyl peptides possess
structural or functional features that allow them to increase the
number of matrix-gene–expressing cells in B. subtilis in a kinD-
independent manner, regardless of their antibiotic activity.
Structure–Function Specificity of Thiocillin’s Activity. We next in-
vestigated the specificity of thiocillin’s activity. We began by exam-
ining the matrix-inducing activity of structural mutants of thiocillin,
including those with disrupted thiazolyl rings (C2A, C5A, C7A, and
C9A), those with a larger ring (A78), and those unable to form a ring
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Fig. 2. Thiocillin contributes to the ability of B. cereus to induce PtapA–yfp gene expression in B. subtilis in a kinD- and antibiotic-independent manner. (A)
Colonies of WT and ΔtclE-H B. cereus spotted onto a lawn of WT or kinD B. subtilis PtapA–yfp microcolonies and quantification of the fluorescence (n = 3). (B)
Colonies of the thiocillin T4V mutant of B. cereus spotted onto the same B. subtilis lawns, as well as quantification of the fluorescence (n = 3). (C) A total of
450 ng of purified thiocillin or T4V thiocillin spotted onto a lawn of WT B. subtilis PtapA–yfp microcolonies and quantification of the fluorescence (n = 3). The
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Fig. 3. Purified thiocillin increases the proportion of matrix-producing B. subtilis
cells in liquid culture, even when not inhibiting growth. (A) Growth curves of B.
subtilis from growth in shaking liquid culture with 12.5 nM YM-266183 or an
equivalent volume of DMSO (gray diamonds, WT with DMSO; black squares, WT
with YM-266183; light green triangles, PtapA–yfp with DMSO; dark green circles,
PtapA–yfpwith YM-266183). (B) Flow cytometry of the fluorescence intensity of B.
subtilis cells harvested from the 9-h time point from A (front, WT cells with
DMSO; middle, PtapA–yfp cells with DMSO; back, PtapA–yfp cells with YM-266183).
A total of 30,000 cells were quantified for each sample.
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(ΔtclM) (refs. 34 and 35 and Figs. S3 and S6). In all cases, when we
spotted B. cereus strains engineered to produce these variants on
a B. subtilis microcolony lawn, we observed that they induced B.
subtilis PtapA–yfp expression to approximately half of the level that
WT B. cereus did and that they had essentially no effect on PtapA–
yfp expression in a lawn of kinD B. subtilis (Fig. 5A). These data
are similar to those observed from the B. cereus ΔtclE-H mutant,
which is unable to produce any of the thiocillins, suggesting that
none of these structural variants are able to induce matrix ex-
pression in B. subtilis.
To confirm that these strains were expressing these thiocillin
variants, we used IMS to detect their expression in vivo. We grew
colonies of the various B. cereus strains on 0.1× LB medium and
assayed for the presence of the masses expected for the different
thiocillin variants; each strain produced at least one compound of
an expected mass (Fig. 5B). These data indicate that, although
disrupting the antibiotic activity of thiocillin does not alter its ability
to induce PtapA–yfp gene expression in B. subtilis, multiple other
structural alterations appear to abolish its ability to induce biofilm
gene expression in B. subtilis.
By quantifying the PtapA–yfp gene expression of B. subtilis in re-
sponse to the naturally produced thiocillin variants YM-266183 and
thiocillin 2, we observed that even minor differences in the thiocillins’
structure (Fig. S6) led to differences in their ability to induce biofilm
in B. subtilis as purified compounds (Fig. S7A). We also observed
that, although the matrix-induction ability of YM-266183 was strong
at 450 ng, it showed a rapid, dose-dependent decrease in activity
when diluted (Fig. S7A). Based on our IMS data, B. cereus appears to
produce numerous thiocillin variants such as the two tested here (Fig.
S1B); whether these compounds act in a synergistic or additive
manner is unknown.
Bacteria with Cryptic Thiazolyl Biosynthesis Genes Induce Matrix in
B. subtilis. Other Bacillus species also have the ability to activate
PtapA–yfp expression via an antibiotic-associated, kinD-inde-
pendent activity (25). Here we quantified the PtapA–yfp fluores-
cence induced by these strains in kinD B. subtilis and compared
it to the fluorescence they causes in WT B. subtilis (Fig. S7B).
These data indicate that three of these strains induce PtapA–yfp
fluorescence in B. subtilis via an entirely kinD-independent
mechanism (Bacillus atrophaeus, Bacillus vallismortis, and Bacillus
mojavensis); unfortunately, there are only partial genome se-
quences available for these strains, making it impossible to de-
termine whether they possess cryptic thiazolyl biosynthesis
genes that could be responsible for this activity. However, we
used the sequences of the biosynthesis genes required for thiazolyl
production [the lantibiotic dehydratase genes (shown in red
in Fig. 6A)] (29), as well as the program antiSMASH (36) to
search all available Bacillus bacterial genomes to identify strains
containing cryptic thiazolyl peptides. We identified 10 Bacillus
strains that contained these putative biosynthetic gene clusters,
consistent with being capable of producing thiazolyl peptides
(37). In addition to the lantibiotic dehydratase genes, these gene
clusters included a YcaO homolog (a cyclodehydratase believed
to catalyze production of thiopeptides’ thaizoles and oxazoles
from cysteines and serines) and one to five copies of a putative
structural gene, as well as other transporters and potential
modification enzymes. Two of these bacterial strains were pub-
licly available, and we tested them for their ability to induce
PtapA–yfp gene expression in WT and kinD B. subtilis (Fig. 6B and
Fig. S8). B. atrophaeus 1942 and Bacillus sp. 107 both induce
matrix gene expression at levels comparable to B. cereus WT, but
only B. atrophaeus 1942 does so in a kinD-independent manner
(Fig. 6B). Interestingly, the biosynthetic gene cluster of Bacillus
sp. 107 appears unique in that it does not contain a dehydro-
genase; it is possible that it does not produce a typical thiazolyl
peptide. Our data suggest that numerous Bacilli can induce ex-
pression of the PtapA–yfp biofilm reporter in B. subtilis via a kinD-
independent manner and that some of these bacteria also contain
putative thiazolyl-producing biosynthetic gene clusters.
Discussion
Antibiotics have frequently been considered merely weapons in
a chemical arms race between soil microbes. Here we show that some
of these killing agents also act as interspecies signals, altering bacterial
gene expression and thus the development of their neighboring
microbes. Specifically, we used a combination of coculture, fluores-
cent reporter assays, and MALDI-TOF IMS to identify and char-
acterize the thiocillins—thiazolyl peptide natural products produced



























































Fig. 4. Purified thiazolyl peptides induce PtapA–yfp gene expression in B. subtilis.
Quantification of fluorescence intensity resulting from spotting 450 ng of the
purified thiazolyl peptides onto a lawn of B. subtilis PtapA–yfp microcolonies
(n = 3–13) is shown. There is no significant difference in PtapA–yfp fluores-
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Fig. 5. Structural modifications to thiocillin abolish its matrix-induction
activity. (A) Quantification of fluorescence intensity of thiocillin mutant
producers spotted onto a lawn of B. subtilis WT (Left) or kinD PtapA–yfp
(Right) microcolonies (n = 3). None of the mutants (gray bars) were signifi-
cantly different from one another on either the WT or kinD B. subtilis lawns,
but each were significantly different from both WT and T4V B. cereus (by at
least P < 0.05 on WT and at least P < 0.0001 on kinD). (B) Images of B. cereus
colonies producing the mutant thiocillins indicated grown on agar on
a MALDI plate with corresponding IMS data; colors represent ions of m/z
indicated: WT [M+H+Na]+; A78 [M+H+Na]+; C2S [M+Na+K]+; C5A [M+H]+;
C7A [M+H+Na]+; C9A [M+H+Na+K]+; ΔtclM [M+H]+.









B. subtilis. Antibiotic-mediated biofilm formation is not a new
phenomenon, but in many instances, it has been thought to be
a nonspecific response to antibiotic challenge (i.e., stress) that
confers increased resistance. Indeed, we initially proposed cell-
type–specific killing as a mechanism for the kinase-independent
interaction between B. subtilis and B. cereus (25). However, using
the T4V mutant of thiocillin, here we showed that thiocillin’s
biofilm-activation activity can be divorced from its antibiotic
activity.
This and previous work (25) indicate that B. cereus and the thio-
cillins activate matrix gene expression independently of the five
sensor histidine kinases (KinA–KinE) known to control the activity of
the master transcriptional regulator Spo0A in B. subtilis. Thus, thio-
cillins do not appear to fall into the class of small molecules that
affect potassium ion concentration (like the lipopeptide surfactin),
which activate matrix through a KinC-dependent pathway (38). We
also found that thiocillin mutants with significant disruptions to the
thiazolyl peptide backbone and major macrocycle were no longer
biofilm-active, whereas structurally diverse thiazolyl peptides from
several different bacterial species all induced matrix production in B.
subtilis. These data suggest that biofilm induction may be generaliz-
able to thiazolyl peptides as a class and that the potential sensor for
these molecules may be capable of responding to general structural
features of this diverse family of compounds. An example of a
receptor for such largely varied structures is provided by the
thiostrepton-inducible protein (Tip) promoter system, found in
Streptomyces and Rhodococcus species, which is capable of recog-
nizing and binding to thiazolyl peptides of diverse structures and
highly up-regulating the expression of its own and other genes (39,
40). At present, no homolog to the Tip transcription factors could be
identified in the genome of B. subtilis NCIB3610, but analogous
receptors could exist in B. subtilis.
Thiazolyl peptides are a growing family of natural products,
with new putative biosynthetic gene clusters being discovered in
diverse bacterial taxa. Historically, many thiazolyl peptides have
been isolated from common soil microbes such as Streptomyces
or Bacillus species. Putative thiazolyl-like biosynthesis genes are
present in ∼4.5% of the currently available Bacillus genome
sequences (10 of 221 genomes), and ∼39% of the available
Streptomyces genomes (35 of 89 genomes), as determined by
antiSMASH (36). Putative thiazolyl-like biosynthetic gene clusters
have also been identified in human skin- and gut-associated
microbes like Propionibacterium acnes and Lactobacillus gasseri
(29), as well as in other bacterial taxa isolated from a variety of
human body sites (41). Thus, the biosynthetic capacity to generate
thiazolyl peptides is not limited to a single bacterial genera or
environmental niche. It is possible that, similar to other classes of
microbial metabolites, thiazolyl peptides may act as signaling cues
within and among these bacterial taxa. We explored this possibility
by showing that two other Bacillus species (harboring related
biosynthesis clusters for as-yet-uncharacterized thiazolyl peptides)
were able to activate matrix gene expression when cocultured with
B. subtilis, although only one did so in a kinD-independent man-
ner. All of the purified thiazolyl peptides tested in our assay
(thiostrepton, nosiheptide, berninamycin, and GE37468; all pro-
duced by Streptomyces) were able to activate the PtapA–yfp fluo-
rescent reporter in B. subtilis to varying degrees, and they did so in
a kinD-independent manner. Together, these data indicate that
thiazolyl peptides can activate biofilm matrix gene expression and
thus may mediate bacterial interspecies interactions.
How the two activities of the thiazolyl peptides (antibiosis and
matrix induction) might interact to shape the distribution, growth,
and development of bacteria in interspecies communities in native-
like environments is still unresolved. Future experiments using
reconstituted synthetic systems or natural environments seeded
with specific microbes should allow us to evaluate the effects of
the WT or antibiotic-null versions of the thiocillins. Our present
data indicate that thiocillin has the ability to increase biofilm
formation in B. subtilis and that the killing and bacterial differ-
entiation activity of this antibiotic can be structurally distin-
guished. Whether other secondary metabolites produced by
microbes (many of which are widely used as therapeutic anti-
biotics) possess bioactivities in addition to antibiosis is an in-
triguing question for future studies. However, the structural
complexity of many secondary metabolites makes it conceiv-
able that they may similarly exert more than one biological
effect. Our work indicates that at least one class of secondary
metabolites—the thiazolyl peptides—is able to induce biofilm
differentiation in B. subtilis using a mechanism that is inde-
pendent of antibiosis.
Materials and Methods
Strains. Strains used in this work are listed in Table S1. The B. subtilis strain
was NCBI3610 from our laboratory collection. The B. cereus strain 14579 was
obtained from ATCC. Mutant B. cereus strains were constructed as in ref. 32.
Culture Conditions and Matrix Induction Assay. Bacterial cultures were grown
and microcolony lawn assays were performed as in ref. 25. Briefly, B. subtilis
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Fig. 6. Bacterial strains containing cryptic thiazolyl peptide biosynthesis genes induce PtapA–yfp gene expression in B. subtilis. (A) Gene clusters comparing
enzyme and peptide sequences for B. cereus, B. atrophaeus, and Bacillus sp. 107. The known precursor peptide sequence is shown in red, with the cleavage
site marked with an asterisk. (B) Quantification of the fluorescence intensity induced by WT B. cereus, B. atrophaeus 1942, and Bacillus sp. 107 in WT and kinD
B. subtilis microcolony lawns (n = 3). Bacillus sp. 107 induction of PtapA–yfp WT and kinD B. subtilis lawns are significantly different (P = 0.0094), but
B. atrophaeus 1942 induction in these two strains is not significantly different, indicating a kinD-independent mechanism of induction. **P < 0.01.
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B. cereus was spotted onto them for coculture growth. See SI Materials and
Methods for details.
Fluorescence Quantification. Typhoon data files were loaded into Metamorph
(Version 7.1), and brightness and contrast were linearly adjusted. Quantifi-
cation was performed as in ref. 25, except that thresholding was not used.
See SI Materials and Methods for details.
Flow Cytometry. B. subtilis liquid cultures with DMSO or Thiocillin (final= 12.5 nM)
added were grown at 37 °C with shaking. Cells were fixed in 4% (wt/vol) para-
formaldehyde, sonicated, and stored at 4 °C until analyzed by flow cytometry. See
SI Materials and Methods for details.
MICs and Growth Curves. B. subtilis cultures were initiated by diluting a mid-
log culture to OD600 = 0.004 in 1 mL of LB in 24-well plates (Falcon). Equiv-
alent volumes of DMSO or thiopeptides were added to separate wells, and
the plates were covered with Aeroseals and grown at 37 °C with shaking.
OD600 measurements were taken by using a Tecan GENios plate reader.
IMS. IMS was performed as described in ref. 31. Briefly, agar coculture samples
were placed onto MALDI-TOF target plates and dried after being coated with
Universal MALDI matrix. Mass spectra were collected from ∼600-μm pixels
across the entire sample, and the distributions of masses were visualized by
using false-color images. See SI Materials and Methods for details.
LC-MS. LC-MS data were acquired on an Agilent 6520 Accurate-Mass Q-TOF
mass spectrometer with an electrospray-ionization source in positive ion
mode. The drying gas temperature was 350 °C, and the fragmentor voltage
was 250 V. The thiazolyl peptides were separated by using a reverse-phase
kinetex column; acetonitrile with 0.1% formic acid was run as a gradient
from 2% to 100% over 15 min and held at 100% for 2 min against water
with 0.1% formic acid.
Thiocillin Purification and Concentrations. Thiocillin, its mutants, and other
thiazolyl peptides were all purified as reported in ref. 32. Purified thiazolyl
peptides were maintained as stocks at a concentration of 250 ng/μL in
DMSO. For matrix induction assays, 1.8 μL (containing 450 ng) was spotted
onto a dried plate freshly inoculated with a B. subtilis reporter micro-
colony lawn.
Statistics. All P values were calculated with a Tukey’s honest significant
difference pairwise analysis using JMP software.
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